Clinical Trial Update: Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating camrelizumab combined with chemotherapy and endoscopic surgery for recurrent nasopharyngeal carcinoma is ongoing with an unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Recurrent Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN